chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received vaccine at 2:00 PM on 3/10//2021.  I was tired afterwards.  By 11:00 that same night I felt nauseous, has a headache and every joint and muscle  in my body was painful.  I could not sleep or get into a position where I was comfortable.   The pain level was a 10.   I took Tylenol in the middle of the night but it did not help.  In the morning I was unable to contact my physician's nurse so I called the 24 hour Nurse Line.  The nurse took all my information and told me that I could take Ibuprofen.  I took 400 mg. and found a lot of relief from that.  I still had some symptoms for the next few days.  By 3/14/21 I felt fine.  Now today I have a stuffy nose which could be an allergy to something else.  I don't know yet.
extreme fatigue; fever 5+ days; headache; diarrhea; This is a spontaneous report from a contactable other healthcare professional (patient herself). A 39-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number EL1283), intramuscular (left arm), on 10Jan2021 13:00, at single dose, for covid-19 immunization. Medical history included allergies: sulfa, venom. Concomitant medications included omeprazole (OMEPRAZEN); duloxetine; cefixime (FLEXERIL); promethazine (PHENERGAN) and; gabapentin. The patient previously took gentamicin and experienced allergies. The patient experienced extreme fatigue, fever 5+ days, headache, diarrhea all on 10Jan2021 at 18:00. These adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received an unspecified treatment for these events. The patient had no other vaccines administered in four weeks and had no Covid prior vaccination. The patient had a rapid Covid test post vaccination via nasal swab on 15Jan2021 with result of negative. The outcome of the events was not recovered.
This is a spontaneous case, initially received from other non-health professional on 20-Dec-2017, concerning a 41-year-old, adult, female pregnant patient with weight of 145 lbs and height of 63 cm. The patient's history included, four previous pregnancies in which one was full term live birth and two elective abortions. The patient's family history had no congenital malformations. The patient had no habit of tobacco, alcohol or illicit drug use. The patient's current condition included anemia and streptococcus agalactiae. The concomitant medication included Ferrousul for anemia, Amoxicillin for streptococcus agalactiae and VITAFOL-ONE for healthy pregnancy. The patient last menstrual period (LMP) was reported as 28-May-2017. On 16-Sep-2017, amniocentesis had performed, and the result was normal (no major congenital malformations noted). On 16-Sep-2017, the patient was administered with AFLURIA QUADRIVALENT (batch number: 00644623A, dose, route of administration, anatomical location and expiry date; not reported), at 16th week of pregnancy. On 18-Oct-2017, ultrasound was performed, and the result were normal (no major congenital malformations noted). The nature of the pregnancy was reported as singleton. The estimated date of delivery (EDD) on 04-Mar-2018. The reporter assessed this case as non-serious.
Fever started Thursday 4/22/21 an hour after injection. Lasted til Sunday 4/25/21. Chills started 4/22/21 an hour after injection. Lasted til 4/25/21. Sweating started 4/22/21. Still experiencing on Monday 4/26/21. Diarrhea started 4/22/21 an hour after shot. Still experiencing 4/26/21. Shaking started 4/22/21 an hour after shot. Still experiencing 4/26/21. Achy body started 4/22/21 an hour after injection. Still experiencing 4/26/21. Sleeping problems, unable to sleep well. Started 4/22/21 still experiencing 4/26/21. Feeling of face falling asleep. Started 4/22/21 an hour after injection. Still experiencing 4/26/21. Arms, legs, fingers and toes have the feeling of falling asleep. Started 4/22/21 an hour after injection. Still experiencing  4/26/21. Headache started 4/22/21 an hour after shot. Still experiencing on 4/26/21. Overall feeling of being off or strange started 4/22/21 an hour after injection. Still experiencing on 4/26/21.
Numbness and tingling occurred in upper left arm within a few minutes. Approximately 5-10 minutes later had swelling in whole let arm, wrist and hand. States numbness and tingling progressed through whole arm. On 11-11-02 she returned to EHS states all symptoms have resolved.
This is a spontaneous report from a contactable physician assistant communicated to a Pfizer sales representative, that reported similar events for two patients. This is the first of two cases. A 17-year-old female patient of an unspecified ethnicity received TRUMENBA, intramuscular on 17Aug2016 at 0.5 ml, single for immunisation. The patient medical history was not reported and concomitant medications were none. The patient experienced felt achy, lightheaded, felt like she had the flu and temperature of 101.8 on 17Aug2016, 1.5 to 2 hours after immunization. Patient was given Zyrtec and Tylenol. Patient completely recovered from all the events on 18Aug2016.
This case was reported by a pharmacist and described the occurrence of injection site redness in a subject of unspecified age and gender who was vaccinated with FLULAVAL (GlaxoSmithKline). On an unspecified date ("within the last 2 weeks" prior to 11 January 2013) the subject received a dose of FLULAVAL (unknown details). On an unspecified date, within the last 2 weeks after vaccination with FLULAVAL, the subject experienced injection site redness and swelling injection site. The events were described as "significant redness and swelling at the injection site. "Last year", on an unspecified date the subject received a dose of FLULAVAL (unknown details). On an unspecified date after vaccination with FLULAVAL, the subject experienced injection site redness and swelling injection site. The events were described as "significant redness and swelling at the injection site. At the time of reporting the outcome of the events were both vaccinations were unspecified.
No adverse effects; The primary reporter reports a 56 year old patient was administered a dose of PROQUAD; This spontaneous report was received from a nurse, regarding a 56 year old patient of unknown gender. The patient's concurrent condition, pertinent medical history, drug reactions, allergies, and concomitant therapies were not reported.   On 22-AUG-2019, the patient of 56 year old was vaccinated with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (appropriate age at vaccine administration) for prophylaxis (strength, route of administration, dose, frequency, lot number and expiration date were not reported). No adverse effects were reported.
Approximately a week after vaccination I began have cough and mild fever. Tested positive on at home COVID-19 test. Had minor weakness for one day. Took a MUCINEX and DELSYM with little to no relief.
Pfizer the initial dose was given instead of Pfizer bivalent.  These patients were also given Pfizer FP7140 instead of Pfizer bivalent:
Information has been received from a licensed practical nurse concerning a female who was vaccinated intramuscularly with a 0.5ml dose of GARDASIL. Subsequently the patient experienced "anxiety". Unspecified medical attention was sought. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
After 45 minutes after the vaccination, I experienced sporadic shooting pains in my wrists.  I developed a fever at approximately 6pm April 7th.  Took 500 mg Tylenol.  At approximately 1AM April 7th, developed chills.  Throughout the night, I went from hot sweats to chills that shook me so badly I shook the bed.  I became quite nauseated, and vomited once.  My right arm was painful and every joint in my body ached.  I could barely walk from the bed to the bathroom, which is approximately a distance of 25 feet. My arm was swollen and the area of the injection site developed a pimple-like raised spot with a bright red area surrounding it.  The upper portion of the arm that had the injection, was mottled and sore.  The gland under the right arm was extremely painful and swollen (and is still tender to the touch today, April 12th). Chills  subsided at approximately 7am April 8th.I took Tylenol 500mg every 4-6 hours, not exceeding 3000mg in a 24-hour period and drank fluids. The fever (102 degrees F) continued until approximately 3pm that afternoon. The evening of April at approximately 7pm, I had another fever, and took more Tylenol and then went to bed. I also had extreme fatigue beginning about two hours post injection.  April 7th, I slept a good part of the day. Saturday April 10th, I felt like myself, and  the only residual effect is a mildly sore arm and tender gland under the right arm.
This spontaneous report was received from a nurse, the patient's mother, and refers to a 13 year old female patient. The patient's medical history included appendicitis at 4th grade and ear tubes at 1 year of age. No concurrent conditions or concomitant therapies were reported. The patient did not have any allergies. On 21-JUL-2016, the patient was vaccinated with the first dose of GARDASIL 9 injection (lot # M011117) (dose, anatomical location and expiration date were not reported) intramuscularly as recommended vaccination. Approximately on 11-AUG-2016 (reported as around three after receiving GARDASIL 9), the patient experienced dizziness and headache that lasted all day long, and on an unspecified date in August 2016 (reported as the week before 18-AUG-2016), she almost passed out in school. The patient sought medical attention with multiple unspecified specialists described as Neurologist, endocrinologist and cardiologist on unspecified dates. The first week of September 2016, the patient underwent a magnetic resonance imaging (MRI) and the result was normal. On an unspecified date, the patient was hospitalized trying to control the headaches. Since that, she experienced tremors in her hands, chest pain, palpitations, fatigue and brain fog (feeling abnormal). The reported stated that she was told that a diagnosis of Postural orthostatic tachycardia syndrome (POTS) orthostatic intolerance and possible Hashimoto's disease (Autoimmune thyroiditis) would occur. It was unknown if the patient received any treatment. The reporter stated that a follow up appointment was scheduled with an unspecified endocrinologist in 6 months (September 2017). The patient had not recovered from the events. The causality between all the events and GARDASIL 9 was not reported. Upon internal review, the event autoimmune thyroiditis was considered as medically significant. Additional information has been requested.
arm soreness; This is a spontaneous report received from a contactable reporter (Consumer) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 71 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "arm soreness".  Additional information: Caller was a 71-year-old female who along with her husband has received both doses of the Pfizer Covid-19 vaccine. The second dose was administered 25Feb2021. She stated that she had no issues with the second dose and only arm soreness after the first dose.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
chills; lack of energy and appetite; lack of energy and appetite; mild fever; sore arm at injection site; This is a spontaneous report from a contactable consumer. This 32-year-old male consumer (patient) reported that:    A 32-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0151) via an unspecified route of administration in Arm Left on 13Apr2021 at 10:30 AM (age at vaccination: 32-years-old) as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. Patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8730) via an unspecified route of administration in Arm Left on 23Mar2021 at 10:30 AM (Age at Vaccination: 32-years-old) as DOSE 1, SINGLE for COVID-19 immunisation and experienced Sore arm at injection site. On 13Apr2021 at 18:00 (on the evening of the same day) patient experienced a mild fever and sore arm at injection site. Next day (14Apr2021) patient had fever, chills, lack of energy and appetite. Patient didn't received treatment for AE. The lab test and procedure includes fever: mild on 13Apr2021 and Fever: Unknown on 14Apr2021. The clinical outcome of the event was recovered on unspecified date on 2021.  No follow-up attempts are possible. No further information is expected.
Patient had a Left ischemic cerebellar stroke on 08/18/2021. Pt started having L sided weakness and clumsiness at 7 pm. Went to the ER at 9 pm. Pt was discharged the next morning and then asked to come back in for an MRI, which confirmed the stroke. Pt is currently on blood thinners and a cardiac monitor for the next 30 days to determine what long term treatment will be.
Per mom, on 9/8 after receiving the BEXSERO vaccine, on the way home, developed stomach pain. By dinner time, started vomiting. Mom then gave Benadryl. THen developed red, itchy rash on legs. By the morning, the rash was generalized. Vomited for 1 day total and nauseated for 3 days total. Rash lasted X 1 week. Had low-grade fever.
At midnight I passed out while on the toilet.  Hitting my head on tile floor.  Laid on back until husband arrived.  Passed out 2 more times on the toilet and then called 911.
pt recvd vax & had Lt Arm discomfort; aching pain from hips down; had difficulty to walk; feeling weird; Lt Arm swollen; red & bruised looking;
This spontaneous report was received from a licensed vocational nurse and refers to an unspecified number of patients of unknown age and gender. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of Gardasil 9 (exact dose, route of administration and anatomical location were not reported, lot # M023169, expiration date 13-JUN-2016). These doses were exposed to 56.80 degrees Fahrenheit (F) for 12 hours and 30 F for 24 hours. A data logger was used to log the temperatures. There were no prior excursion. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Reported: "Half-dollar" raised, felt like areas of erythema at both injection sites.  "Extremely sore arms", "unable to touch" - entire arm sore.  "Sick" for 1 week after injection - low grade fever.
My father woke up 16 days after Pfizer medication was injected.  According to his story, he briefly exercised, developed extreme chest pain.  His significant other was present and took him to the ER and Medical Center.  After obtaining EKG, the ER determined he was having an MI.  Appropriate medication were initiated, he was stabalized, and transferred by ambulance to hospital.  He received 2 stents in the LAD and an angioplasty for a blockage "further down".
Patient with Pfizer vaccines x3, last dose 10/01/21, who admitted to hospital after weakness in conjunction with COVID detected test.  No respiratory symptoms during stay.  Provider discharge note below:  "69 WM fully vaccinated to COVID-19. Recently discharged from hospital 1/19/22 for L Int capsule bleed. Was doing OK at home receiving Homecare and home physical therapies. Tested positive for COVID approx 1/21/22. Homecare and therapies were held due to his COVID positivity. Admitted with multiple falls and physical debility. Patient was complaining of waxing and waning left sided weakness, likely increased physical debility. MRI brain negative for newer findings. He had no respiratory symptoms and his COVID precautions were discontinued. Patient was successfully discharged for an IPR facility for intensive PT care."
felt so tired; some pain in the arm where got the vaccine; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 41 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 31Mar2021 10:30 (Batch/Lot number: unknown) at the age of 41 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Penicillin Allergy" (unspecified if ongoing); "Sulpha" (unspecified if ongoing), notes: Sulpha allergy; "food allergy" (unspecified if ongoing), notes: food Allergy. The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 01Apr2021, outcome "recovered", described as "felt so tired"; VACCINATION SITE PAIN (non-serious) with onset 01Apr2021, outcome "recovered", described as "some pain in the arm where got the vaccine". Therapeutic measures were not taken as a result of fatigue, vaccination site pain.  Additional information: Adverse event- 24 hours after the vaccination felt so tired and got a nap for almost three hours. After that he felt well. In addition, some pain in the arm where got the vaccine. The patient had allergy to medications, food, or other products included penicillin, sulphas and certain foods. The patient had no other vaccine within four weeks and no other medications received within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
No adverse event; Dose administered after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) in a 29-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 013B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 01-Dec-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 01-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry).    No concomitant medication was reported.    Date the vial was initially stored in the refrigerator on 01-Dec-2022. Vial size was 5.5mL.The vial did not undergo any temperature excursions. Manufacturer date of expiration given as 22-NOV-2022.  No treatment information was reported.
pt was found slumped in chair early morning of 17NOV97;they think pt had a heart attack according to wife;
I started running a high fever and in bothered me because I have seizures regularly . I feel real tired since I've been vaccinated . I wish I hadn't got vaccinated .
This spontaneous report was received from a nurse and refers to multiple unspecified patients of unknown age and gender. No information about the patients' pertinent medical history, concomitant medications, drug reactions or allergies was provided. On unknown dates, the patients were administered improperly stored doses of VAQTA lot # M003011 with expiration date 15-NOV-2017 (dose and route of administration not reported). The vaccine underwent a temperature excursion of 0.5 degrees Celsius for 2 hours. Digital Data Logger was involved. There was no previous temperature excursions. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
A report has been received from a Health Professional concerning a patient, Female subject, who had been receiving Nasal FLUMIST QUADRIVALENT (Intranasal). FLUMIST QUADRIVALENT (Intranasal) started on an unknown date. The patient received expired FLUMIST QUADRIVALENT. She did not experience any adverse events. The outcome of the event of expired FLUMIST QUADRIVALENT administered is unknown. The report was considered to be non-serious by the reporter.
High fever, extreme fussiness, possible seizure (twitching of extremities and trunk). Decreased appetite and activity.
Patient states that he began having intermittent episodes of dyspnea and left sided chest pressure shortly after receiving his COVID-19 vaccine. Received the vaccine April 2021, chest pain developed shortly thereafter and in June patient was diagnosed with incurable rectal cancer with metastatic lesions to left upper lobe.  In October of 2021, patient developed pain/swelling over right neck, right arm. He was diagnosed with DVT in right internal jugular, the subclavian vein,  a thrombus in the upper portion of the right basilic vein and a superficial vein. He was also diagnosed with a pulmonary embolism.
This case was reported by a nurse and described the occurrence of injection site pruritis in a 33 year old female pt who received hepatitis A inactivated and hepatitis B recombinant vaccine (Twinrix) for prophylaxis.  The pt's medical history included allergies to nickel and mercury.  Concurrent medications were not reported.  On 07/08/03, the pt received her first dose of Twinrix.  On 08/08/03, the pt received the second dose of Twinrix.  On the same date, at an unspecified time post-immunization, the pt experienced itching at the injection site.  The itching persisted as of 10/27/03.  The reporting nurse considered the event was possibly related to vaccination with Twinrix.
Day of vaccine- headache, very sore arm. 7 days later- redness on shoulder, very itchy on injection site and torso( mostly back), bruise, pain at injection site with painful lump under injection site.
She was 17 and received the Moderna vaccine in error, she should had received the Pfizer.  However, today we are completing the series per CDC guidelines with Moderna dose #2.
Pt reported to pharmacy that less than 24 hours after receiving injection she had a large painful bruise at the injection site. After visiting her physician she reported to pharmacy the severity of the pain and bruising. Pt reported applying heat and taking otc pain relievers. Pt is improving but still experiencing discomfort.